NetworkNewsBreaks – FinCanna Capital Corp. (CSE:
Post# of 30

Royalty company for the U.S. licensed medical cannabis industry FinCanna Capital (CSE: CALI) (OTCQB: FNNZF) today announced its advancement of $750,000 to investee company Refined Resin Technologies Inc., an Oakland, California-based cannabinoid research and extraction company. This is FinCanna’s third and final tranche of its $3 million capital commitment to Refined Resin to fund the build out and operationalization of its 6,000 square foot, state-of-the-art medical cannabis extraction laboratory. “We are very pleased to see the company hitting key milestones as it moves towards full commercialization,” FinCanna Capital President and CEO Andriyko Herchak stated in the news release. “With its strong leadership team in place we have every confidence that the company will deliver a first class facility and with its deeply rooted industry relationships continue to build on its already growing order book to the benefit of both Refined Resin and our FinCanna shareholders.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

